XML 13 R4.htm IDEA: XBRL DOCUMENT v3.22.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
$ in Thousands
Total
At The Market
Public Offering
Common Stock
Common Stock
At The Market
Common Stock
Public Offering
Additional Paid-In Capital
Additional Paid-In Capital
At The Market
Additional Paid-In Capital
Public Offering
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance at Dec. 31, 2020 $ 104,179     $ 2     $ 319,196     $ (177) $ (214,842)
Beginning balance, shares at Dec. 31, 2020       24,773,361              
Proceeds from issuance of common stock, net of issuance costs   $ 1,180           $ 1,180      
Proceeds from issuance of common stock, net of issuance costs, shares         57,100            
Proceeds from issuances of common stock under employee stock plans 121           121        
Proceeds from issuances of common stock under employee stock plans, shares       31,620              
Stock-based compensation 2,687           2,687        
Foreign currency translation gain (loss) 38                 38  
Unrealized loss on marketable securities (50)                 (50)  
Net loss (16,514)                   (16,514)
Ending balance at Mar. 31, 2021 91,641     $ 2     323,184     (189) (231,356)
Ending balance, shares at Mar. 31, 2021       24,862,081              
Beginning balance at Dec. 31, 2020 104,179     $ 2     319,196     (177) (214,842)
Beginning balance, shares at Dec. 31, 2020       24,773,361              
Foreign currency translation gain (loss) 108                    
Unrealized loss on marketable securities (68)                    
Net loss (32,624)                    
Ending balance at Jun. 30, 2021 217,579     $ 3     465,179     (137) (247,466)
Ending balance, shares at Jun. 30, 2021       29,475,921              
Beginning balance at Mar. 31, 2021 91,641     $ 2     323,184     (189) (231,356)
Beginning balance, shares at Mar. 31, 2021       24,862,081              
Proceeds from issuance of common stock, net of issuance costs   $ 3,510 $ 134,582     $ 1   $ 3,510 $ 134,581    
Proceeds from issuance of common stock, net of issuance costs, shares         157,871 4,356,060          
Proceeds from issuances of common stock under employee stock plans 1,016           1,016        
Proceeds from issuances of common stock under employee stock plans, shares       99,909              
Stock-based compensation 2,888           2,888        
Foreign currency translation gain (loss) 70                 70  
Unrealized loss on marketable securities (18)                 (18)  
Net loss (16,110)                   (16,110)
Ending balance at Jun. 30, 2021 217,579     $ 3     465,179     (137) (247,466)
Ending balance, shares at Jun. 30, 2021       29,475,921              
Beginning balance at Dec. 31, 2021 186,380     $ 3     470,629     (206) (284,046)
Beginning balance, shares at Dec. 31, 2021       29,555,119              
Proceeds from issuances of common stock under employee stock plans 132           132        
Proceeds from issuances of common stock under employee stock plans, shares       37,640              
Stock-based compensation 2,702           2,702        
Foreign currency translation gain (loss) (201)                 (201)  
Unrealized loss on marketable securities (710)                 (710)  
Net loss (20,468)                   (20,468)
Ending balance at Mar. 31, 2022 167,835     $ 3     473,463     (1,117) (304,514)
Ending balance, shares at Mar. 31, 2022       29,592,759              
Beginning balance at Dec. 31, 2021 186,380     $ 3     470,629     (206) (284,046)
Beginning balance, shares at Dec. 31, 2021       29,555,119              
Foreign currency translation gain (loss) 349                    
Unrealized loss on marketable securities (888)                    
Net loss (39,652)                    
Ending balance at Jun. 30, 2022 202,133     $ 3     526,573     (745) (323,698)
Ending balance, shares at Jun. 30, 2022       29,649,457              
Beginning balance at Mar. 31, 2022 167,835     $ 3     473,463     (1,117) (304,514)
Beginning balance, shares at Mar. 31, 2022       29,592,759              
Proceeds from sale of pre-funded warrants in private placement, net of issuance costs 49,784           49,784        
Proceeds from issuances of common stock under employee stock plans 654           654        
Proceeds from issuances of common stock under employee stock plans, shares       56,698              
Stock-based compensation 2,672           2,672        
Foreign currency translation gain (loss) 550                 550  
Unrealized loss on marketable securities (178)                 (178)  
Net loss (19,184)                   (19,184)
Ending balance at Jun. 30, 2022 $ 202,133     $ 3     $ 526,573     $ (745) $ (323,698)
Ending balance, shares at Jun. 30, 2022       29,649,457